Total Payments
$13,161
2024 Payments
$520.71
Companies
23
Transactions
149
Medicare Patients
2,467
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$5,820 (44.2%)
Travel$3,655 (27.8%)
Food & Beverage$2,904 (22.1%)
Consulting$770.00 (5.9%)
Education$12.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,820 | 9 | 44.2% |
| Travel and Lodging | $3,655 | 10 | 27.8% |
| Food and Beverage | $2,904 | 127 | 22.1% |
| Consulting Fee | $770.00 | 2 | 5.9% |
| Education | $12.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Paratek Pharmaceuticals, Inc. | $10,872 | 50 | $0 (2024) |
| ORGANOGENESIS INC. | $450.43 | 6 | $0 (2021) |
| GlaxoSmithKline, LLC. | $226.31 | 8 | $0 (2024) |
| Novo Nordisk Inc | $210.65 | 15 | $0 (2024) |
| Smith+Nephew, Inc. | $194.75 | 12 | $0 (2024) |
| ABBVIE INC. | $184.15 | 16 | $0 (2024) |
| Medtronic, Inc. | $174.29 | 5 | $0 (2021) |
| TRIAD LIFE SCIENCES INC. | $106.67 | 3 | $0 (2022) |
| Amgen Inc. | $105.26 | 5 | $0 (2024) |
| Lilly USA, LLC | $104.14 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $520.71 | 37 | ABBVIE INC. ($161.45) |
| 2023 | $1,972 | 38 | Paratek Pharmaceuticals, Inc. ($1,360) |
| 2022 | $8,358 | 47 | Paratek Pharmaceuticals, Inc. ($7,979) |
| 2021 | $2,310 | 27 | Paratek Pharmaceuticals, Inc. ($1,510) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: ANTIBIOTIC | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Pharma Products | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: DIABETES | ||||||
| 06/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Inflammation | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Obesity | ||||||
| 04/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,468 | 2,885 | $273,424 | $83,806 |
| 2022 | 14 | 420 | 1,174 | $2.2M | $952,355 |
| 2021 | 2 | 25 | 31 | $6,157 | $1,715 |
| 2020 | 9 | 554 | 1,162 | $271,887 | $54,745 |
Total Patients
2,467
Total Services
5,252
Medicare Billing
$1.1M
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 402 | $88,842 | $29,586 | 33.3% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 30 | 164 | $49,200 | $12,267 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 186 | $28,086 | $10,058 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 117 | 117 | $39,078 | $8,601 | 22.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $8,968 | $3,858 | 43.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 60 | 60 | $7,500 | $3,627 | 48.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $7,329 | $2,733 | 37.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 141 | 230 | $1,840 | $1,803 | 98.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 109 | 136 | $4,080 | $1,408 | 34.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 36 | 83 | $3,403 | $1,346 | 39.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 126 | 167 | $3,674 | $1,271 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $5,060 | $1,226 | 24.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 78 | 89 | $5,429 | $1,168 | 21.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 30 | 33 | $3,630 | $1,142 | 31.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 70 | 70 | $2,450 | $994.70 | 40.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 56 | 73 | $1,971 | $694.96 | 35.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 72 | $2,448 | $560.64 | 22.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $1,073 | $412.09 | 38.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 22 | 23 | $943.00 | $372.60 | 39.5% |
| 83550 | Iron binding capacity | Office | 2023 | 13 | 16 | $384.00 | $137.12 | 35.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 17 | 17 | $272.00 | $103.87 | 38.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 47 | $282.00 | $103.40 | 36.7% |
| 83540 | Iron level | Office | 2023 | 13 | 16 | $288.00 | $101.44 | 35.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 49 | 237 | $2,070 | $87.33 | 4.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 17 | $238.00 | $86.36 | 36.3% |
About Stephen Rohrer, CNP
Stephen Rohrer, CNP is a Acute Care healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2016. The National Provider Identifier (NPI) number assigned to this provider is 1538611975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephen Rohrer, CNP has received a total of $13,161 in payments from pharmaceutical and medical device companies, with $520.71 received in 2024. These payments were reported across 149 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,820).
As a Medicare-enrolled provider, Rohrer has provided services to 2,467 Medicare beneficiaries, totaling 5,252 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Primary Care
- Location Wynne, AR
- Active Since 11/02/2016
- Last Updated 12/20/2024
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538611975
Products in Payments
- NUZYRA (Drug) $10,872
- Puraply (Medical Supply) $287.97
- Puraply Antimicrobial (Medical Supply) $162.46
- VRAYLAR (Drug) $143.94
- FlowMet-R (Device) $130.00
- TRELEGY ELLIPTA (Drug) $122.25
- INNOVAMATRIX AC (Device) $106.67
- MOUNJARO (Drug) $104.14
- RENASYS GO v2 HOME (Device) $98.39
- Dermatology and Wound Care (Medical Supply) $97.24
- GRAFIX PL (Medical Supply) $80.81
- Ozempic (Drug) $78.52
- EVENITY (Biological) $74.30
- Cologuard Collection Kit (Device) $70.86
- Wegovy (Drug) $66.68
- JARDIANCE (Drug) $61.72
- Rybelsus (Drug) $52.16
- YUPELRI (Drug) $51.19
- GEMTESA (Drug) $50.57
- MENQUADFI (Biological) $44.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.